RespireRx Pharmaceuticals Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
RespireRx Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2022.
  • RespireRx Pharmaceuticals Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $29.2K, a 33% increase year-over-year.
  • RespireRx Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $143K, a 85.1% decline from 2021.
  • RespireRx Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $957K, a 92.5% increase from 2020.
  • RespireRx Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $497K, a 5.52% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $143K -$814K -85.1% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-17
2021 $957K +$460K +92.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 $497K +$26K +5.52% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2019 $471K +$95.4K +25.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-15
2018 $376K -$314K -45.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-14
2017 $690K -$678K -49.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-16
2016 $1.37M +$178K +15% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-17
2015 $1.19M +$136K +13% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 $1.05M +$1.01M +2260% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
2013 $44.6K -$334K -88.2% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-30
2012 $378K -$99.4K -20.8% Jan 1, 2012 Dec 31, 2012 10-K 2015-01-06
2011 $478K -$994K -67.5% Jan 1, 2011 Dec 31, 2011 10-K 2014-10-14
2010 $1.47M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.